Comparison Chart aTyr Pharma, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 01/06/2024 am IST			5-day change	1st Jan Change
1.73 ^USD	-1.70%		-3.89%	+22.70%

14/05	ATyr Pharma, Inc. Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT? Study in Pulmonary Sarcoidosis	CI
02/05	ATyr Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	ATYR PHARMA, INC.	Other Biotechnology & Medical Research	-1.70%	-3.89%	+22.70%	-23.79%	-71.40%	12Cr